The content below will be hidden until launched in lightboxes. To make changes, edit the code block.
Chairman & CEO
Steve sets the strategic direction for Remedy and manages the relationship with CMS.
Steve has over 30 years of experience launching and managing health care companies and has founded seven health care companies including Oxford Health Plans, which grew into a Fortune 300 company under his leadership. Steve is a Managing Director of Essex Woodlands Health Ventures, one of the oldest and largest health care venture capital and growth equity firms, with over $2.5 billion under management.
He was also the Founder, Chairman and Chief Executive Officer of HealthMarket, Inc., an insurance company that gave birth to innovative Consumer Driven Health Plans and grew to over $150 million in revenue before being acquired by UICI. He co-founded Health Partners, Inc, a physician practice management company that grew to $140 million in annual revenue before it was sold. He was also a co-Founder of Intelliclaim, Inc., which provided claim auditing and productivity software and services to over twenty health insurance companies before it was sold to McKesson, and he was the founding investor in BenefitPort, LLC, a consolidation of health insurance general agencies.
Steve has also been an active private equity investor on his own and in partnership with private equity funds, typically originating transactions or organizing new businesses.
Steve is a Director of Accessible Space, Inc, a non-profit organization he founded in 1978, which operates residential facilities for individuals with mobility impairments and brain injuries. Steve graduated from Macalester College and has an MBA from Harvard Business School.
Chief Financial Officer
Chris manages finances, the team and forward progress at Remedy.
Prior to Remedy, Chris spent two years at Enhanced Equity Funds as a managing partner, leading their investments in hospital supply chain management, non-emergency transport services, specialty pharmacy distribution and pain management services.
In 1992, Chris formed an episode management company focused on managing care for work-related injuries on behalf of property and casualty insurers. During his tenure, National Healthcare Resources developed a specialty preferred provider group, built a telephonic case management strategy to manage episodes and grew to $170 million in annual revenue before being sold to Concentra Managed Care in 2002.
From 2003-2010, Chris spent 7 years with private equity team at the Charterhouse Group as an operating partner, leading their investments in behavioral healthcare services, out-patient rehabilitation, Medicaid eligibility and business process outsourcing for healthcare claims.
Chris is a Certified Public Accountant and holds a Bachelor of Science in Accounting from the University of Florida.
Chief Operating Officer
Robert C. Meier, has served as the Chief Operating Officer at Remedy Partners since February, 2014.
Prior to joining Remedy Partners, he served as Chief Executive Officer of Dahlman Rose, a boutique investment bank, which was acquired by Cowen & Company in March, 2013. Prior to his tenure at Dahlman Rose, he served as the Chief Executive Officer of the Equity Division of Gleacher & Company until October, 2011. Prior to joining Gleacher in 2008, he served as Co-Head of Equities and Global Head of Sales at Cowen & Company, a healthcare-focused investment bank. Beginning in 1995, he served in various sales and sales management positions with Soundview Technology Group, a technology investment bank, culminating with his role as Senior Vice President and Head of Global Sales for Schwab Soundview Capital Markets after the sale to Charles Schwab in 2004.
A lawyer by training, he spent six years practicing corporate and entertainment law, first at Rogers & Wells and later at Loeb & Loeb. He received a B.A. in Economics from Franklin & Marshall College in 1985 and a J.D. from the University of Pennsylvania Law School in 1988.
Chief Strategy Officer/Co-Founder
Charlie builds teams and organizes partnerships at Remedy. Charlie served as a President of Field Operations from 2011 to 2015. During that time, Remedy implemented the first 22 "pioneer" episode programs which covered over 45,000 lives across 7 states - the largest and most progressive federal demonstration project at the time. Most recently, Charlie launched our Care Innovation center, which improves the lives of nearly 1 million patients and care givers annually while focusing on episode research, quality improvement and product testing. Charlie also guides our marketing, design, brand, and creative teams.
Prior to Remedy, Mr. Wiggins served as Vice-President of Tomorrow Networks, a technology platform enabling physician connectivity. Mr. Wiggins is an alumnus of the Healthcare Industry Group at Alvarez & Marsal in New York and was an early member of the Los Angeles based Newscorp/Myspace digitial incubator, Slingshot Labs.
During the course of his career, Mr. Wiggins has dedicated much of his time as a volunteer, mentor and coach to a variety of youth organizations promoting healthy lifestyles.
Charlie received a BA from the University of Maryland and a Masters in Health Administration from the Johns Hopkins School of Public Health.
Chief Information Officer
Ed is responsible for building the technology and infrastructure necessary to support the implementation of bundled payment programs and other episode financing business lines. Ed has over thirty years of experience in the healthcare and information technology industries.
Ed worked with Steve Wiggins as Executive Vice President and Chief Information Officer of HealthMarket, Inc., an insurance company that gave birth to innovative Consumer Driven Health Plans that grew to over $150 million in revenue before being acquired by UICI.
Prior to joining Remedy, Ed spent four years as Executive Vice President and Chief Technology Officer of Sandata Technologies, LLC. Previously he held executive and senior level positions with IT Analytics LLC, Touchstone Health Partnership, HealthMarkets, Inc., Thomson Healthcare and SportsTicker, Inc.
Ed holds a B.A. in Computer Science from the State University of New York. He is also a Director of Cryoport Inc.
Eric Shuey is President and Co-Founder of Liberty Health Partners. Prior to founding LHP, Mr. Shuey served as the Chief Financial Officer of Liberty Dialysis LLC, played an instrumental role in growing this business into a leading national provider of dialysis services. Mr. Shuey has approximately twenty years of corporate finance and private equity investing experience.
Prior to joining Liberty Dialysis, he served as a Director at DB Capital Partners, the private equity arm of Deutsche Bank responsible for over $10 billion in assets, and a Principal at Aurora Capital Group, a $1 billion private equity firm. Mr. Shuey earned an MBA from the Wharton School of Business, where he was a Palmer Scholar and graduated with distinction. He earned his BA from California State University, Fullerton, where he graduated with highest honors.
Chief Human Resources Officer
Leslie Glenn joined Remedy Partners in May 2015 as the Chief Human Resources Officer.
Leslie is an experienced Human Resources executive with experience across diverse industries and companies, including start-up environments, as well as large global organizations. Prior to joining Remedy Partners, Leslie was the Chief Human Resources Officer at Bonnier Corporation, one of the largest consumer-publishing groups in the U.S.
Prior to her role at Bonnier, Leslie was the Director of People for Say Media, a digital media start-up. Leslie also held multiple human resources management roles at General Electric (GE), including at GE Energy Financial Services and GE Asset Management. Leslie started her HR career at Energizer Holdings, and held various roles of increasing responsibility. Leslie’s responsibilities during her time with Energizer Holdings included compensation, talent acquisition, leadership development, organizational design and change management.
Leslie received a BS in Industrial and Labor Relations from Cornell University and an MBA from Washington University in St. Louis.
Matt is focused on identifying and developing entrepreneurial opportunities within the bundled payments ecosystem that can help Remedy and it's partners operate more effectively. He was responsible for recruiting provider partners (hospitals, SNFs, physician groups) into the Remedy BPCI program and sourcing talent for the organization.
Prior to Remedy Partners, he built a healthcare focused mobile technology company called Remedy Systems with Nir Pengas, Nick Fisser, and others - which now serves as the core technology team for Remedy Partners. Remedy Systems originated ideas and designed platforms that could be piloted on the fringes of healthcare and then brought to scale through strategic channel partners. This included the first mobile ePrescribing app, the first mobile telemedicine platform (acquired by TelaDoc), the first physician-only mobile messaging platform leveraging real-time-bidding (acquired by Merck), a mobile health information exchange (acquired by Optum), and a platform for automated Medicare risk adjustment.
Outside of healthcare, Matt originates ideas, raises money, and assembles teams for special projects or emerging opportunities. This has led to the creation of a leading mobile demand side platform (DSP) for marketers and advertisers; the first entertainment listings app (acquired by Tribune); an early massive online open course (MOOC) focused on political education (acquired by NewsCorp), and an award winning documentary film about young people in America called "Our Time".
His current explorations are Music Therapy, Sweat Therapy, and Food-As-Medicine - which are fueled by his life mission of designing a reimbursement model for the necessary elements of a modern American healthcare system.
Matt graduated from Boston College holding a BS in Political Science, with an emphasis on the comparative cultural and political revolutions.
Win Whitcomb, MD
Chief Medical Officer
Win Whitcomb, MD, MHM, is Chief Medical Officer of Remedy Partners, where he oversees all aspects of the clinical enterprise, and the intersection between clinical, technology, and business areas. Prior to joining Remedy, Dr. Whitcomb led the development and implementation of several bundled payment programs at Baystate Health in conjunction with its commercial health plan and the Center for Medicare and Medicaid Innovation.
A practicing hospitalist for the past twenty years, Win has led the development of the hospitalist specialty since 1994, when he assumed leadership of the nation’s first 24/7 on-site hospitalist program. Dr. Whitcomb is cofounder and past president of the Society of Hospital Medicine, and has lectured widely, written numerous articles, and authored three books on the clinical and administrative aspects of hospital medicine. He has been on the ground floor of a myriad of initiatives that form the foundation of the hospitalist movement, including working with the American Board of Internal Medicine to create board certification for hospitalists.
Dr. Whitcomb was one of the first three to receive hospital medicine’s most prestigious achievement award, the Master in Hospital Medicine, in April 2010. He is Assistant Professor of Medicine at the University of Massachusetts Medical School. Dr. Whitcomb completed his internal medicine residency at Tufts University/Baystate Medical Center, received an MD from Jefferson Medical College, and a BA from Wesleyan University.
Mark Caputo is the founder and CEO of Liberty Health Partners. Prior to LHP, Mark was the founder and CEO of Liberty Dialysis LLC, which he grew from one clinic in 2002 to the third largest dialysis company in the world, serving more than 20,000 ESRD patients in more than 280 dialysis centers, with hospital and physician partners in 32 states. In 2012, Liberty Dialysis merged with Fresenius Medical Care, in a transaction valued at $2.35 billion.
During the course of his career, Mr. Caputo has served as (i) Chairman of the Board of Sound Physicians, Inc., the largest hospitalist company in the United States, employing more than 2,000 physicians, and (ii) Board Member and investor in National Cardiovascular Partners, a business that grew to become the largest outpatient cardiac cath lab business in the United States.
During the course of his career, Mr. Caputo has dedicated much of his time to assisting non-profit organizations ranging from St. Francis Medical Center in Honolulu to St. Joseph’s Hospital in Syracuse, to Northwest Children’s Fund in Seattle, and the Little Sisters Fund in Nepal. In addition, he has served as an advisor to technology companies from Boston to Seattle. He received his M.B.A. from Harvard Business School and B.A. in Economics from Princeton University.
George W. Carmany, III
George is a finance industry executive whose later career has involved him actively in hospital management and the provision of health care. He served as the head of strategic planning of American Express Company, and as a leader of several of its operating units, including the Boston Company, a major asset management and private banking company. Since the sale of the company to Mellon Financial Corporation, he has served as a director of numerous corporations, including Sun Life Financial, a leading global life insurer; founding director the Macquarie Infrastructure Company which, since 2009, has been one of the top ten performing companies on the NYSE; Senior Advisor to Brown Brothers Harriman, and Chairman of the Olympia and York bondholders steering committee
George’s extensive experience in healthcare and related science has included the Chairmanship of the New England Medical Center Hospitals; Vice Chairman of Lifespan Inc; Senior Advisor to Essex Woodlands; membership on the Advisory Committees on Education and Health Care Policy of the Harvard Medical School; and Chairmanship of the Board of Associates of the Whitehead Institute for Biomedical Research.
At the request of the Cold Spring Harbor Laboratory George acted as CEO of Helicon Therapeutics, a biotechnology company sponsored by the laboratory, Roche Pharmaceuticals, and OSI Pharmaceuticals. He is a founding investor of Remedy and of EnGeneIc Pty. Ltd., a biotechnology company located in Sydney, Australia. He was for twenty years a trustee and member of the executive committee of Bentley University.
George is a graduate of Amherst College, where he held various alumni offices. He is the organizer and sponsor of its annual symposium on healthcare and bioscience, which has attracted leaders in their fields from around the country. The college has awarded him both its Distinguished Service Award and Medal for Eminent Service.
Mike is a Managing Director at Bain Capital Ventures and he focuses on technology and technology-driven companies, including software, hardware, database, and telecommunication services. Prior to Bain Capital Ventures, Mike was a Managing Director with the Private Equity Group of Bain Capital. Earlier in his career at Bain Capital, Mike was a Principal of Information Partners, a fund focused on early-stage information technology investing. He has also served in several operating roles as President of a $110 M revenue software company and CFO of a $70 M revenue services company. Prior to joining Bain Capital in 1991, Mike was a consultant with Bain & Company.
In addition to his firm and portfolio responsibilities, Mike coaches lacrosse and soccer and has served on the Board of the Boys and Girls Club of Boston for 17 years.
Mike earned a BA in Chemistry from Dartmouth College.
W. Robert Dahl
Mr. Dahl is currently a private investor, focusing on the healthcare industry. Previously, he was the co-founder and Chief Operating Officer of Arrowhawk Capital Partners, an investment company and the Vice President of Strategic Business Development and Vice Chairman of the Board of Directors of Golden Pond Healthcare, Inc. From 1999 until 2006, Mr. Dahl served as the head of Global Healthcare for the Carlyle Group, a leading private equity firm, where he was responsible for the firm's investments in the healthcare field. Prior to Carlyle, Mr. Dahl served as co-head of healthcare investment banking in North America at Credit Suisse First Boston. Mr. Dahl is a director of several private companies. He is also a member of the Board of Trustees of the Cancer Research Institute and YMCA Camp Belknap. Mr. Dahl received a BA from Middlebury College and an MBA with high distinction from the Harvard Business School.
Dawn Owens is currently President,TripleTree Holdings. Dawn most recently served as CEO of OptumHealth, from 2007 through 2012, part of the Minnesota-based UnitedHealth Group (NYSE: UNH).
Under her leadership, OptumHealth became one of the nation's largest and most respected health and well-being companies. Dawn joined UnitedHealth Group in 1997 and held numerous leadership positions, including Chief Marketing Officer of Ingenix (now OptumInsight), and President of Uniprise (now a part of UnitedHealthcare). She began her healthcare career at Aetna Health Plans.
Dawn advises companies in various stages of development and serves on the boards of Grove City College, in Grove City, PA and the Walker Art Center in Minneapolis, MN.
Dawn holds a bachelor's degree in International Business and German from Grove City College and studied at Marburg University in Germany. She also attended the John F. Kennedy School of Government at Harvard University.
Corporate Social Responsibility Officer
Shannon has been part of Remedy Partners since its inception in 2012. For the first three years of the company’s history, she acted as Remedy’s Accounting Manager. In the spring of 2015, she transitioned to Corporate Social Responsibility Officer. In this role, Shannon works with the Strategy Team to develop innovative programs and partnerships that affect Remedy’s impact on the local community and the environment.
For the past 15 years, Shannon has been active in various non-profit organizations and humanitarian efforts, both in the US and abroad. She is the founder and Executive director of a non-profit organization that funds civil rights educational programs for women in Africa.
Shannon received a BA from New York University in Economics and Computer Applications and an MFA in Poetry from Sarah Lawrence College.
Chief Executive Officer
Carolyn Magill is the CEO of Remedy Partners, the Episodes of Care Company. Carolyn sets the strategic direction and manages daily operations of Remedy, which has more than 300 employees and manages more than 2,200 bundled payment programs in partnership with leading healthcare organizations.
Carolyn brings significant leadership and healthcare experience to Remedy. She was the Executive Vice President of Payer Strategy and Operations at Evolent Health (EVH) prior to joining Remedy. There she led the team responsible for operationalizing value-based payer contracts and provider-led health plans serving populations enrolled in Medicare, Medicaid, Commercial, and Exchange programs. During her four-year tenure, Evolent grew from a start-up with fewer than 50 employees and $8 million in annual revenue to a public company with more than 1,000 employees and $150 million in revenue.
Carolyn has also served in several leadership roles within the Medicare and Medicaid businesses of UnitedHealth Group (UNH). As Chief Operating Officer of UnitedHealth Group’s Community and State plan in New Jersey, Carolyn drove a financial and cultural turnaround and grew membership to more than 400,000 beneficiaries. Prior to that, she was the Vice President of Medicare Special Needs Plans, serving as the national product lead for health plans tailored to individuals with chronic illnesses and limited incomes.
Early in her career Carolyn was a management consultant both in the Strategic Change Group of PricewaterhouseCoopers and in the health and life sciences division of Silverline Technologies.
Carolyn earned her undergraduate degree at Harvard University and her MBA in healthcare management from the Wharton School of Business at the University of Pennsylvania.